CHO Genome Sequenced by BGI and GT Life Sciences

Quick Links In the News Analysis & Insight Webinars App Notes   Online Exclusives More at GEN Subscriber Tools   GEN NEWS HIGHLIGHTS Thursday, January 6, 2011 View email in a browser           Forward to a colleague SPONSORED LINK Make your Biomanufacturing voice heard! Support effective industry growth & planning. 8th Annual Biomanufacturing study benchmarks critical global trends: Budget, new technologies, capacity, outsourcing hiring, downstream, disposables, expression systems, cost cutting, quality, more. BioPlan Associates, Inc. FREE summary, plus donation to GAVI, or ACS Click Here! Receive FREE summary CHO Genome Sequenced by BGI and GT Life Sciences Next step is data analysis and interpretation of genetic regulation in cell proliferation. Genentech and Pfizer Join the Antibody-Drug Conjugate Bandwagon Genentech will tap Spirogen's technology and Pfizer will use Seattle Genetics'. Symphogen Raises About $134M to Progress Clinical-Stage Antibodies Firm claims fundraising is largest ever in Europe by private biotech business. Investigators Identify Prognostic Marker for Treating Hep C with Peg-Interferon and Ribavirin Team expects to launch a test based on the IP-10 marker this year. Researchers Develop Simpler, Quicker Way of Producing AAV-Based Vectors for Gene Transfer Method is also capable of producing high yields of multiple AAV serotypes and efficient packaging. Cell Medica and Baylor's CAGT Ally to Commercialize EBV-CTL Cancer Therapy Partners will develop commercial GMP process and hope to start Phase II/III study in 2012. GSK Licenses Immutep's T-Cell Depleting Antibodies for Autoimmune Diseases Firm hopes selective depletion of activated T cells will lead to longer-lasting, safer therapy. Horizon and University of Washington Partner to Apply Gene Editing to IPSCs $400,000 project aims to generate new X-Man cell lines and bioproduction reagents. Receptos and Lilly Enter Agreement Focused on a GPCR Target Receptos' technology will be used to find small molecule modulators. Chiva Nabs Chinese Rights to Ligand's Hep B and HCC Candidates Use of Ligand's HepDirect tech for the development of new candidates against hep B, hep C, and HCC part of deal. You can view more news broken down into over 90 categories and updated daily. Analysis & Insight 2010 in Review: Biotechnology Highlights Gene patenting and ESCs were back in the headlines along with breakthroughs in sequencing, syn bio, and other fields.     More A&Is Webinars Available on Demand: Original Broadcast Date - December 16, 2010 Simplifying Targeted Protein Quantification with Mass Spec: The SRM Atlas and Multiplexed MRM Protein Assays Sponsored by: Agilent Technologies In Case You Missed It: If you couldn't attend a previous webinar, be sure to check out our On-Demand Archives. Application Note Library Analysis of an O-linked Glycopeptide Using Multiple Stage Mass Spectrometry Reliability of Size Exclusion Chromatography Measurements on the ACQUITY UPLC H-Class Bio System Reproducible Dispensing of Live Cells with the Thermo Scientific Multidrop Combi Reagent Dispenser Improving Immunoassay Sensitivity Using IDBS ActivityBase to Enable Biofuel Discovery More App Notes Online Exclusives BLOGBIOTECH: Will FDA Bid Adieu to Auld Lang Syne and Open Up to New Drugs and Devices    More Blogs More at GEN GEN Subscriber Tools Subscription Center l Unsubscribe l Update Your Profile l About GEN IMPORTANT! Make sure you receive your chosen GEN e-Newsletters. Add update@genengnews.com to your Address Book or Safe Senders List. It's easy! Click HERE for instructions. Contact Us For: Advertising   Editorial   Business and Partnership Opportunities This email was sent by: Genetic Engineering & Biotechnology News 140 Huguenot St., New Rochelle, NY 10801, USA